Abstract
From July 2020 to June 2021, 248 wild house mice (Mus musculus), deer mice (Peromyscus maniculatus), brown rats (Rattus norvegicus), and black rats (Rattus rattus) from Texas and Washington, USA, and British Columbia, Canada, were tested for SARS-CoV-2 exposure and infection. Two brown rats and 11 house mice were positive for neutralizing antibodies using a surrogate virus neutralization test, but negative or indeterminate with the Multiplexed Fluorometric ImmunoAssay COVID-Plex, which targets full-length spike and nuclear proteins. Oro-nasopharyngeal swabs and fecal samples tested negative by RT-qPCR, with an indeterminate fecal sample in one house mouse. Continued surveillance of SARS-CoV-2 in wild rodents is warranted.
References
Bosco-Lauth AM, Root JJ, Porter SM, Walker AE, Guilbert L, Hawvermale D, Pepper A, Maison RM, Hartwig AE, Gordy P, Bielefeldt-Ohmann H, Bowen RA (2021) Peridomestic mammal susceptibility to severe acute respiratory syndrome Coronavirus 2 infection. Emerging Infectious Diseases 27:2073–2080. https://doi.org/10.3201/eid2708.210180
Charles River Laboratories International, Inc. (2020) Development of COVID-Plex MFIA for Detection of Antibodies against SARS-CoV-2 (COVID-19). https://www.criver.com/sites/default/files/resource-files/RM-MFIA-covid-plex-report-summary.pdf
Charles River Laboratories (2018) Serologic Methods Manual: Multiplexed Fluorometric ImmunoAssay (MFIA). https://www.criver.com/sites/default/files/resource-files/RM-serology-methods-manual-MFIA.pdf
Colombo VC, Sluydts V, Mariën J, Vanden Broecke B, Van Houtte N, Leirs W, Jacobs L, Iserbyt A, Hubert M, Heyndrickx L, Goris H, Delputte P, De Roeck N, Elst J, Ariën KK, Leirs H, Gryseels S (2022) SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium. Transboundary and Emerging Diseases 69:3016–3021. https://doi.org/10.1111/tbed.14219
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DGJC, Haagmans BL, Van Der Veer B, Van Den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MPG, Drosten C (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045
Earnest R, Hahn AM, Feriancek NM, Brandt M, Filler RB, Zhao Z, Breban MI, Vogels CBF, Chen NFG, Koch RT, Porzucek AJ, Sodeinde A, Garbiel A, Keanna C, Litwak H, Heidi R, Cantoni JL, Pitzer VE, Castillo XAO, Goodman LB (2023) Survey of white-footed mice in Connecticut , USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses. NPJ Viruses 1:10.–42 https://doi.org/10.1038/s44298-023-00010-4
Fisher AM, Airey G, Liu Y, Gemmell M, Thomas J, Bentley EG, Whitehead MA, Paxton WA, Pollakis G, Paterson S, Viney M (2023) The ecology of viruses in urban rodents with a focus on SARS-CoV-2. Emerging Microbes and Infections 12. https://doi.org/10.1080/22221751.2023.2217940
Gadkar VJ, Goldfarb DM, Al-Rawahi GN, Srigley JA, Smailus DE, Coope RJN, Pleasance S, Watson N, Chen T, Lam S, Hoang L, Tilley PAG (2023) Extraction-free clinical detection of SARS-CoV-2 virus from saline gargle samples using Hamilton STARlet liquid handler. Scientific Reports 13:1–11. https://doi.org/10.1038/s41598-023-30993-2
Griffin BD, Chan M, Tailor N, Mendoza EJ, Leung A, Warner BM, Duggan AT, Moffat E, He S, Garnett L, Tran KN, Banadyga L, Albietz A, Tierney K, Audet J, Bello A, Vendramelli R, Boese AS, Fernando L, Lindsay LR, Jardine CM, Wood H, Poliquin G, Strong JE, Drebot M, Safronetz D, Embury-Hyatt C, Kobasa D (2021) SARS-CoV-2 infection and transmission in the North American deer mouse. Nature Communications 12:1–10. https://doi.org/10.1038/s41467-021-23848-9
Hale VL, Dennis PM, McBride DS, Nolting JM, Madden C, Huey D, Ehrlich M, Grieser J, Winston J, Lombardi D, Gibson S, Saif L, Killian ML, Lantz K, Tell RM, Torchetti M, Robbe-Austerman S, Nelson MI, Faith SA, Bowman AS (2022) SARS-CoV-2 infection in free-ranging white-tailed deer. Nature 602:481–486. https://doi.org/10.1038/s41586-021-04353-x
Henderson KS, Perkins CL, Havens RB, Kelly MJE, Francis BC, Dole VS, Shek WR (2013) Efficacy of direct detection of pathogens in naturally infected mice by using a high-density PCR array. J Am Assoc Lab Anim Sci 52:763–772
Kuchipudi SV, Surendran-Nair M, Ruden RM, Yon M, Nissly RH, Vandegrift KJ, Nelli RK, Li L, Jayarao BM, Maranas CD, Levine N, Willgert K, Conlan AJK, Olsen RJ, Davis JJ, Musser JM, Hudson PJ, Kapur V (2022) Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer. Proceedings of the National Academy of Sciences of the United States of America 119:1–8. https://doi.org/10.1073/pnas.2121644119
Meerburg BG, Brom FWA, Kijlstra A (2008) The ethics of rodent control. Pest Management Science 64:1205–1211. https://doi.org/10.1002/ps.1623
Miot EF, Worthington BM, Ng KH, Guilhem De, de Lataillade L, Pierce MP, Liao Y, Ko R, Shum MH, Cheung WY, Holmes EC, Leung KS, Zhu H, Poon LL, Malik Peiris JS, Guan Y, Leung GM, Wu JT, Lam TT (2022) Surveillance of rodent pests for SARS-CoV-2 and other coronaviruses, Hong Kong. Emerging Infectious Diseases 28:467–470. https://doi.org/10.3201/eid2802.211586
Montagutelli X, van der Werf S, Rey FA, Simon‐Loriere E (2022) SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance. EMBO Molecular Medicine 14:1–2. https://doi.org/10.15252/emmm.202115558
Nagorsen, DW (2002) An identification manual to the small mammals of British Columbia. Available: https://a100.gov.bc.ca/pub/eirs/lookupDocument.do?fromStatic=true&repository=BDP&documentId=2941 [Accessed June 25, 2021]
Oude Munnink BB, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, Van Der Spek A, Tolsma P, Rietveld A, Brouwer M, Bouwmeester-Vincken N, Harders F, Hakze-Van der Honing R, Wegdam-Blans MCA, Bouwstra RJ, Geurtsvankessel C, van der Eijk AA, Velkers FC, Smit LAM, Stegeman A, van der Poel WHM, Koopmans MPG (2021) Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 371:172–177
Robinson SJ, Kotwa JD, Jeeves SP, Himsworth CG, Pearl DL, Weese JS, Lindsay LR, Dibernardo A, Toledo NPL, Pickering BS, Goolia M, Chee H-Y, Blais-Savoie J, Chien E, Yim W, Yip L, Mubareka S, Jardine CM (2023) Surveillance for SARS-CoV-2 in Norway Rats (Rattus norvegicus) from Southern Ontario. Transboundary and Emerging Diseases 2023:1–9. https://doi.org/10.1155/2023/7631611
Sharun K, Dhama K, Pawde AM, Gortázar C, Tiwari R, Bonilla-Aldana DK, Rodriguez-Morales AJ, de la Fuente J, Michalak I, Attia YA (2021) SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications. Veterinary Quarterly 41:181–201. https://doi.org/10.1080/01652176.2021.1921311
Shuai H, Chan JFW, Yuen TTT, Yoon C, Hu JC, Wen L, Hu B, Yang D, Wang Y, Hou Y, Huang X, Chai Y, Chan CCS, Poon VKM, Lu L, Zhang RQ, Chan WM, Ip JD, Chu AWH, Hu YF, Cai JP, Chan KH, Zhou J, Sridhar S, Zhang BZ, Yuan S, Zhang AJ, Huang JD, To KKW, Yuen KY, Chu H (2021) Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine 73:1–12. https://doi.org/10.1016/j.ebiom.2021.103643
Strang T, Flockhart L, Thacker C, Schwantje H, Soos C, Dibernardo A, Lindsay L, Toledo N, Beauclerc K, Fraser E, Prystajecky N, Himsworth C (2022) SARS-CoV-2 wildlife surveillance surrounding mink farms in British Columbia Canada, Canada. Communicable Disease Report 48:252–260
Tan CW, Chia WN, Qin X, Liu P, Chen MIC, Tiu C, Hu Z, Chen VCW, Young BE, Sia WR, Tan YJ, Foo R, Yi Y, Lye DC, Anderson DE, Wang LF (2020) A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nature Biotechnology 38:1073–1078. https://doi.org/10.1038/s41587-020-0631-z
Wang Y, Lenoch J, Kohler D, DeLiberto TJ, Tang CY, Li T, Tao YJ, Guan M, Compton S, Zeiss C, Hang J, Wan XF (2023) SARS-CoV-2 Exposure in Norway Rats (Rattus norvegicus) from New York City. mBio 14. https://doi.org/10.1128/mbio.03621-22
Wunderlich ML, Dodge ME, Dhawan RK, Shek WR (2011) Multiplexed fluorometric immunoassay testing methodology and troubleshooting. Journal of Visualized Experiments 1–7. https://doi.org/10.3791/3715
Zhang C, Cui H, Li E, Guo Z, Wang T, Yan F, Liu L, Li Y, Chen D, Meng K, Li N, Qin C, Liu J, Gao Y, Zhang C (2022) The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice. Frontiers in Immunology 13:1–7. https://doi.org/10.3389/fimmu.2022.869809
Acknowledgements
We thank all participating pest control professionals, notably Jeremy Logsdon and other specialists from Preventive Pest Control who contributed immense time and resources to this project, in addition to members of the Structural Pest Management Association of British Columbia for their expertise in animal collection. We thank staff at the BC Centre for Disease Control and Animal Health Centre for laboratory processing, as well as Chris Huynh and Nikki PI Toledo at the National Microbiology Laboratory for their technical expertise.
Author information
Authors and Affiliations
Corresponding author
Technical Appendix
Technical Appendix
COVID-Plex and Mouse Hepatitis Virus Multiplexed Fluorometric ImmunoAssay (MFIA)
Nobuto strip eluants from cardiac blood and thoracic fluid were submitted to Charles River Laboratories, Research Animal Diagnostic Services (Wilmington, MA) for serologic testing for SARS-CoV-2 (COVID-Plex MFIA) and mouse hepatitis virus (MHV MFIA).
SARS-CoV-2-specific recombinant spike-full length and nuclear proteins were individually coupled to MagPlex magnetic microspheres (beads) for analysis. In addition, four seasonal coronavirus strain-specific spike full-length protein coupled beads (229E, OC43, HKU1, and NL63 causing the common cold) were added to the panel to check cross-reactivity with SARS-CoV-2-specific spike full-length protein. Internal control beads including wild-baculovirus-infected SF + cell lysate as tissue control and species-specific IgG and anti-IgG as sample and system suitability controls were also in the panel.
The MFIA procedure was performed following the online manual (Charles River Laboratories, 2018). For each assay, the net median fluorescence intensity signal was calculated by subtracting the tissue control from the antigen median fluorescence intensity. Net scores were calculated from net MFIA values based on cutoffs and formulas as described in the manual. Values of < 1.5 and ≥ 3 were classified as negative and positive, respectively; net signals between these cutoffs were called equivocal/indeterminate. A sample was considered SARS-CoV-2 antibody-positive if both full-length spike and nuclear protein antigen-coupled beads were individually positive (i.e., if antibodies against both beads were present).
Standard positive assay control (immune sera) was convalescent serum from SARS-CoV-2-infected humans that had been confirmed positive by PCR. Standard negative assay control sera (species-specific non-immune) were serum pools collected from SARS-CoV-2 antibody-free animals, from which samples were collected prior to 2019.
For detection of MHV antibodies, MFIA was performed as described as above. The MHV assay employs three different bead sets with the following antigens: a purified recombinant nuclear protein for MHV-A59, as well as partially purified whole virus lysates for both MHV-A59 and MHV-S strains coupled to individual bead sets.
Mouse Hepatitis Virus Real-Time PCR
Terminal rectum with feces, oro-nasopharyngeal swabs, and kidneys from mice were submitted to Charles River Laboratories (Wilmington, MA) for MHV PCR testing. Total nucleic acid was extracted from pooled samples using the MagMAX Total Nucleic Acid Isolation Kit (Life Technologies, Carlsbad, CA) using a Qiagen robotic extraction station (Thermo Labsystems, Franklin, MA). Proprietary 3’endonuclease real-time PCR primers and probes were designed to target a conserved region of the MHV nucleocapsid protein (Charles River Laboratories, Wilmington, MA). Betacoronavirus sequences obtained from laboratory mouse, rat, and other wild rodents, which represented both GenBank (NCBI) or unpublished geographically diverse sequences, were aligned to design a broadly cross-reactive assay for MHV detection. PCR assay qualification methods, sample processing and nucleic acid isolation procedures, commercially available reagents, and lab-specific PCR sample and system suitability controls are previously described (Henderson et al. 2013).
Rights and permissions
About this article
Cite this article
Lee, L.K.F., Himsworth, C.G., Prystajecky, N. et al. SARS-CoV-2 Surveillance of Wild Mice and Rats in North American Cities. EcoHealth 21, 1–8 (2024). https://doi.org/10.1007/s10393-024-01679-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10393-024-01679-6